» Articles » PMID: 16292499

Acrylamide-induced Changes in the Neurofilament Protein of Rat Cerebrum Fractions

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2005 Nov 18
PMID 16292499
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Acrylamide (ACR) is known to produce central-peripheral distal axonopathy, which is characterized by distal swellings and secondary degeneration both in experimental animals and human. Ultrastructurally, excessive accumulation of neurofilaments (NFs) in the distal swollen axon is a major pathological hallmark. However, the mechanisms of ACR axonopathy remain unknown. Twenty seven male Wistar rats were randomly divided into three groups. Lower and higher ACR groups were received 20 and 40 mg/kg ACR by i.p. injection respectively. The control group received physiological saline. All rats were sacrificed after 8 weeks of treatment and their cerebrums were dissected, homogenized and used for the determination of the NF proteins. In general, the levels of light NF (NF-L) and medium NF (NF-M) subunits increased consistently in the supernatant, whereas they decreased consistently in the pellet from rats treated with ACR. Compared to that of the control group, the levels of NF-L increased respectively by 104% and 45% (P<0.01) in the supernatant and decreased by 16% and 11% (P<0.01) in the pellet of rat cerebrums in lower and higher groups. The enhancement of NF-M was 76% and 147% (P<0.05, P<0.01) in supernatant, and the reduction was 26% and 36% (P<0.01) in pellet in lower and higher group respectively. The heavy NF (NF-H) level changed slightly. The present results suggested that the change of NF-L and NF-M levels in cerebrum might be relevant to the mechanisms of the neurofilamentous axonopathies induced by ACR.

Citing Articles

Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury.

Vlasakova K, Tsuchiya T, Garfinkel I, Ruth M, Tyszkiewicz C, Detwiler T Front Neurosci. 2024; 17:1285359.

PMID: 38292901 PMC: 10824906. DOI: 10.3389/fnins.2023.1285359.


The Mechanism of Acrylamide-Induced Neurotoxicity: Current Status and Future Perspectives.

Zhao M, Zhang B, Deng L Front Nutr. 2022; 9:859189.

PMID: 35399689 PMC: 8993146. DOI: 10.3389/fnut.2022.859189.


Protective effect of rosemary on acrylamide motor neurotoxicity in spinal cord of rat offspring: postnatal follow-up study.

Al-Gholam M, Nooh H, El-Mehi A, El-Barbary A, Fokar A Anat Cell Biol. 2016; 49(1):34-49.

PMID: 27051566 PMC: 4819076. DOI: 10.5115/acb.2016.49.1.34.


Neuroprotective Effect of Calpeptin on Acrylamide-Induced Neuropathy in Rats.

Wei X, Yan F, E M, Zhang C, Li G, Yang X Neurochem Res. 2015; 40(11):2325-32.

PMID: 26423962 DOI: 10.1007/s11064-015-1722-y.


Neurotoxicity of acrylamide in exposed workers.

Pennisi M, Malaguarnera G, Puglisi V, Vinciguerra L, Vacante M, Malaguarnera M Int J Environ Res Public Health. 2013; 10(9):3843-54.

PMID: 23985770 PMC: 3799507. DOI: 10.3390/ijerph10093843.


References
1.
LoPachin Jr R, Lehning E . Acrylamide-induced distal axon degeneration: a proposed mechanism of action. Neurotoxicology. 1994; 15(2):247-59. View

2.
Xu Z, Cork L, Griffin J, Cleveland D . Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 1993; 73(1):23-33. DOI: 10.1016/0092-8674(93)90157-l. View

3.
Zhu Q, Couillard-Despres S, Julien J . Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol. 1997; 148(1):299-316. DOI: 10.1006/exnr.1997.6654. View

4.
Xie K, Gupta R, Abou-Donia M . Alteration in cytoskeletal protein levels in sciatic nerve on post-treatment of diisopropyl phosphorofluoridate (DFP)-treated hen with phenylmethylsulfonyl fluoride. Neurochem Res. 2001; 26(3):235-43. DOI: 10.1023/a:1010916617208. View

5.
Barber D, LoPachin R . Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes. Toxicol Appl Pharmacol. 2004; 201(2):120-36. DOI: 10.1016/j.taap.2004.05.008. View